Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) is a global leader in cannabis production and consumer goods innovation. This news hub provides investors and industry observers with official press releases, financial updates, and strategic developments from one of the sector's most diversified companies.
Access real-time updates on CGC's medicinal cannabis research, recreational product launches, and international market expansions. Our curated collection includes earnings reports, partnership announcements, and regulatory compliance milestones across Canada, Europe, and U.S. markets through Canopy USA.
Key focus areas include vaporizer technology advancements, brand portfolio growth, and cultivation process innovations. Users will find detailed information on THC and CBD product developments, sustainability initiatives, and strategic moves in emerging cannabis markets.
Bookmark this page for direct access to verified CGC announcements. Check regularly for updates on clinical trials, retail partnerships, and operational developments that shape the company's position in the global cannabis industry.
Canopy Growth (TSX: WEED) (Nasdaq: CGC) has launched Spectrum Reserve, a new premium medical cannabis brand in Canada through its medical division Spectrum Therapeutics. The brand focuses on premium genetics selected for size, potency, and terpene levels.
The program will introduce new strains regularly based on patient feedback, with successful strains remaining in market while others are phased out. The initial release includes four flower strains:
- Power Plant x Super Silver Haze (Indica, 22-25% THC, 2.21% terpenes)
- Grape Star x Golden Lemons (Sativa, 22-25% THC, 1.77% terpenes)
- Malawi x Kosher Tangie (Hybrid, 27-30% THC, 2.59% terpenes)
- Raspberry Parfait (Sativa-Dominant Hybrid, 22-27% THC, 2.59% terpenes)
Canopy Growth (TSX: WEED, Nasdaq: CGC) has made an optional early prepayment of US$100 million on its senior secured term loan at a discounted price of US$97.5 million. This strategic move will result in annual interest expense savings of approximately US$13 million.
The prepayment, completed under the Term Loan Amendment agreement with senior lenders, extends the loan's maturity date to September 18, 2027. The company had the option to make this Second Prepayment by March 31, 2025.
According to CFO Judy Hong, this action strengthens Canopy's balance sheet by reducing overall debt position and lowering annual interest costs, with no material debt obligations until September 2027.
Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA , has launched hemp-derived Delta-9 THC gummies in Texas, marking its 22nd state expansion. The product line includes eight varieties of gummies, each containing 20 pieces with 100mg THC and 100mg CBD in different flavors and effects combinations.
The products will be available at select retail locations across major Texas metropolitan areas including Austin, Dallas, and Houston. The product lineup features various formulations under the Balance, Relax, Inspire, and Dream Berry collections, each designed for specific wellness needs.
All products undergo third-party testing for potency, purity, and contaminants. This expansion beyond the Wanderous marketplace represents a strategic move to increase market share through improved product accessibility at local retail locations.
Wana Brands, a subsidiary of Canopy USA , has announced nationwide availability of its THC-infused beverages at Total Wine & More stores. The strategic partnership aims to meet growing consumer demand for health-conscious, zero-proof alcohol alternatives.
The product line features three varieties in 12 oz cans:
- Wana Lemonade Balance Blend (5mg each of CBG, CBD, THCA)
- Wana Strawberry Lemonade Balance Blend (10mg each of CBG, CBD, THCA)
- Wana Raspberry Tea Relax Blend (5mg each of CBG, CBD, THCA)
The beverages are available in select states including AZ, TX, IN, FL, NC, SC, KE, NE, and NJ, both in stores and online through totalwine.com. The products feature artwork by illustrator Beto Val and are formulated using hemp-derived cannabinoids for consistent effects.
Canopy Growth (NASDAQ: CGC) has announced a new US$200 million at-the-market equity program that enables the company to issue and sell common shares in concurrent public offerings in the United States and Canada. The shares will be sold at prevailing market prices through Nasdaq and TSX.
The net proceeds will be used for:
- Corporate investments and potential acquisitions
- Working capital and general corporate purposes
- Debt repayment, including an optional US$100 million prepayment that would extend the company's term loan maturity to September 18, 2027
The ATM Program will be effective until the earlier of the complete sale of shares, regulatory cessation, or July 5, 2026. BMO Nesbitt Burns Inc. and BMO Capital Markets Corp. will serve as agents for the program.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has launched its Tweed brand in the German medical cannabis market, introducing four new strains through a partnership with Portuguese cultivator Gro-Vida. The new offerings include Jack Herer (sativa-dominant), Balanced Caramel and Wappa (indica-prominent), and Gelato 33 (balanced hybrid).
This expansion follows the December 2024 launch of Tweed's Glitter Bomb strain in Germany through an agreement with German-based Cansativa. The company aims to provide consistent, reliable flower supply to meet growing patient demand for higher-THC genetics, leveraging both EU-based cultivators and their EU-GMP facility in Canada.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has expanded its Deep Space Propulsion beverage lineup with two new cannabis-infused flavors: Rocket Root Beer and Charged Cream Soda. These additions join the existing Blue Sourberry and Altitude Lemon Lime offerings.
Each 355ml can contains 10mg of THC, 10mg of CBG, and less than 30mg of naturally occurring caffeine. The beverages are crafted with natural flavors, with Rocket Root Beer featuring a deep, rich taste and Charged Cream Soda offering a smooth vanilla cream experience.
The new products are now available at licensed cannabis retailers across select Canadian regions and through the Spectrum Therapeutics online store for medical consumers.
Canopy Growth (CGC) reported Q3 FY2025 financial results, with net revenue of $74.8 million, representing a 5% decrease year-over-year. However, excluding divested businesses, net revenue increased 8% driven by growth in medical cannabis and Storz & Bickel segments.
Key highlights include: Storz & Bickel revenue grew 19% year-over-year to $22 million; Canada medical cannabis revenue increased 16%; and international markets cannabis revenue grew 14%. The company's gross margin decreased 400 basis points to 32%. Operating loss improved 61% to $24 million, while Adjusted EBITDA loss improved 61% to $3 million.
The company successfully launched Claybourne infused pre-rolls in Canada, achieving #3 market share in British Columbia and Ontario after 6 weeks. Total debt decreased to $442 million from $554 million, primarily due to early prepayment of senior secured term loan.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has announced it will release its third quarter fiscal 2025 financial results on February 7, 2025, before market open. The results will cover the period ended December 31, 2024.
The company will host an audio webcast featuring CEO Luc Mongeau and CFO Judy Hong on February 7 at 10 AM Eastern Time. The webcast will be available live, with a replay accessible until May 8, 2025.
Canopy USA has appointed M. Brooks Jorgensen as its first-ever President, effective January 6, 2025. Jorgensen brings over 25 years of leadership experience in cannabis, wine, and spirits industries. Most recently, he served as President of Kiva Sales and Service, developing it into the largest full-service cannabis products distributor in the U.S.
Following the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA is positioned across key U.S. cannabis market segments including flower, edibles, vapes, and extracts, with retail presence through The Botanist locations in the Midwest and Northeast. The U.S. cannabis market is projected to reach $50 billion in sales by 2026.
Jorgensen's appointment follows a comprehensive search by the Canopy USA Board of Managers and the recent Acreage acquisition announced on December 9, 2024. In his role, he will oversee the continued integration of Canopy USA's operations as a unified platform.